![Daniel Curran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Curran
Director/Board Member at
XILIO THERAPEUTICS, INC.
Net worth: - $ as of 2026-05-30
Profile
Daniel J.
Curran is Chief Executive Officer at Timberlyne Therapeutics, Inc. since 2025.
He is an Independent Director at Xilio Therapeutics, Inc. since 2020.
He serves as Director at Catalyst Pharmaceuticals, Inc. since 2025.
He is Director at Stargazer Pharmaceuticals, Inc. since 2019.
He is an Independent Director at ALX Oncology Holdings, Inc. since 2025.
He is Managing Partner at Mountainfield Venture Partners LLC since 2024.
Formerly, Dr. Curran was Director at Tome Biosciences, Inc. in 2024.
He was Director at Oak Hill Bio Corp.
from 2022 to 2024.
He was Principal at DuPont Merck Pharmaceutical Co. He was Vice President-Business & Corporate Development at Millennium Pharmaceuticals, Inc. from 1999 to 2008.
He was Senior VP, Head-Rare Genetics & Hematology at Takeda Pharmaceutical Co., Ltd. from 2019 to 2023.
Education includes undergraduate studies at King's College (Pennsylvania) and a doctorate from the University of Pennsylvania Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 0 ( -.--% ) | - $ | 2026-05-30 | |
| 2026-06-10 | 0 ( -.--% ) | - $ | 2026-05-30 | |
| 2026-06-02 | 0 ( -.--% ) | - $ | 2026-05-30 |
Daniel Curran active positions
| Companies | Position | Start |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Director/Board Member | 2020-11-30 |
| CATALYST PHARMACEUTICALS, INC. | Director/Board Member | 2025-08-03 |
| ALX ONCOLOGY HOLDINGS INC. | Director/Board Member | 2025-08-11 |
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Director/Board Member | 2018-12-31 |
Former positions of Daniel Curran
| Companies | Position | End |
|---|---|---|
Tome Biosciences, Inc.
 Tome Biosciences, Inc. BiotechnologyHealth Technology Provides genomic medicine insertion and technologies services | Director/Board Member | 2024-10-31 |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization that develops medicines | Director/Board Member | 2024-02-29 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 2023-11-30 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 2007-12-31 |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Corporate Officer/Principal | - |
Training of Daniel Curran
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Catalyst Pharmaceuticals, Inc.
 Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
King's College (Pennsylvania)
 King's College (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
 University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Stargazer Pharmaceuticals, Inc.
Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Tome Biosciences, Inc.
Tome Biosciences, Inc. BiotechnologyHealth Technology Provides genomic medicine insertion and technologies services | Health Technology |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization that develops medicines | Commercial Services |
- Stock Market
- Insiders
- Daniel Curran
